e-learning
resources
Paris 2018
Monday, 17.09.2018
New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical courses of asymptomatic patients with mild idiopathic pleuroparenchymal fibroelastosis
M. Toyoshima (Hamamatsu, Japan), A. Fukada (Hamamatsu, Japan), D. Akahori (Hamamatsu, Japan), T. Suda (Hamamatsu, Japan)
Source:
International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Session:
New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Session type:
Poster Discussion
Number:
2231
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Toyoshima (Hamamatsu, Japan), A. Fukada (Hamamatsu, Japan), D. Akahori (Hamamatsu, Japan), T. Suda (Hamamatsu, Japan). Clinical courses of asymptomatic patients with mild idiopathic pleuroparenchymal fibroelastosis. 2231
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Clinical and pathological features of idiopathic and secondary pleuroparenchymal fibroelastosis in patients undergoing lung transplantation
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Treatment with nintedanib in patients with pleuroparenchymal fibroelastosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
The health status in idiopathic pleuroparenchymal fibroelastosis
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Familial cases of idiopathic pulmonary fibrosis: Clinical observation
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Clinical features of patients with idiopathic pulmonary upper lobe-dominant fibrosis
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Considerations of a warm autopsy program for patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
Source: ERJ Open Res, 7 (1) 00196-2020; 10.1183/23120541.00196-2020
Year: 2021
Registry of idiopathic pulmonary fibrosis patients
Source: International Congress 2016 – Russia Session
Year: 2016
Clinical investigation of idiopathic pleuroparenchymal fibroelastosis cases diagnosed by radiologic findings and fibroelastosis obtained by TBLB
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015
Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Prognostic evaluation in Chinese patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Clinical course and morphological signs of idiopathic pulmonary fibrosis and interstitial pneumonias
Source: Eur Respir J 2004; 24: Suppl. 48, 536s
Year: 2004
Approach to diagnosis of idiopathic pulmonary fibrosis
Source: International Congress 2016 – Russia Session
Year: 2016
A rare case of idiopathic pulmonary fibrosis in children
Source: Eur Respir J 2007; 30: Suppl. 51, 390s
Year: 2007
Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Characteristic of four exercise tests in patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients
Year: 2018
Outcomes in idiopathic pulmonary haemosiderosis in children are highly heterogeneous
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Idiopathic pulmonary hemosiderosis in childhood – review of 43 cases
Source: Eur Respir J 2006; 28: Suppl. 50, 263s
Year: 2006
How to follow-up patients with hereditary haemorrhagic telangiectasia and suspected pulmonary arteriovenous malformations
Source: Eur Respir J 2016; 47:1618-1621
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept